12,372 trials
Respiratory Syncytial Virus
Primary: Percentage of Participants With Local Reactions Within 7 Days After Vaccination — 12.4; 3.2; 11.6; 2.4 Percentage of participants
Schizophrenia
Primary: Change From Baseline in Overall Composite T-score of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery…
Onchocerciasis
Primary: Incidence and Severity of Treatment Emergent Adverse Events — 346; 79; 1199; 288 participants
HIV Infections
Primary: Number of Participants With Continued Access to Age Appropriate Formulation of Dolutegravir — 53; 29 Participants
Schizophrenia
Primary: Number of Participants With Adverse Events (AEs) — 5; 58; 54; 63 Participants
Knee Osteoarthritis
Primary: Change From Baseline OA Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) at Week 12 — -2.15; -2.22 units on a scale…
Neuroendocrine Neoplasms
Primary: Number of [68Ga]Ga-DOTA-TATE Positive Participants (TP Participants) Among CIM Positive Participants (TP or FN Participants) — 40; 6 Participants
Lung Cancer · Cancer
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Treatment Related AEs (TRAEs) — 10; 5; 3; 4 Participants
Pain
Primary: Sedation — 0; 0; 1; 1 UMSS score
Obesity · Uric Acid Stones · Type 2 Diabetes Mellitus in Obese
Primary: Kidney Stone Size (mm^3) Determined by Non-contrast CAT Scan — 6540; 4650; 3120; 5041 mm^3
Acanthamoeba Keratitis · Fungal Keratitis
Primary: Best Spectacle-Corrected Visual Acuity — 0.614; 0.666 logMAR
Blood Pressure · Stroke · Cardiovascular Diseases
Primary: Systolic Blood Pressure — 67; 43 participants — p=<0.001
Non-radiographic Axial Spondyloarthritis
Primary: Assessment of SpondyloArthritis International Society 40 (ASAS40) Response Rate in TNF-alpha-inhibitor-naive Participants at Week 16 — 58.72; 26.03 Percentage of…
Brain Tumor, Primary · Brain Tumor, Recurrent
Primary: Diagnostic Quality of Cerebral Blood Volume (CBV) Map of Dynamic Susceptibility Contrast MRI (DSC-MRI) Perfusion — 58; 63 Participants
Lymphatic Filariasis
Primary: Clearance of Microfilaremia (IA vs. MoxA) — 8; 18; 24; 27 Participants